Status:
UNKNOWN
Mitral Annuloplasty Rings RCT
Lead Sponsor:
University Health Network, Toronto
Conditions:
Degenerative Mitral Valve Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Recently published work has suggested that mitral valve annuloplasty ring type may affect the development of post-repair mitral stenosis resulting in adverse intracardiac hemodynamics and poor functio...
Eligibility Criteria
Inclusion
- Mitral regurgitation secondary to degenerative valve disease referred to Prof Tirone David (Co-investigator) will be invited to take part.
- The mitral valve anatomy must be anatomy suitable for repair.
- The patient must be able to perform treadmill exercise echocardiography.
- The patient must be over 18 years of age.
Exclusion
- Any presence of life-limiting disease process, for example advanced malignancy.
- Hemodynamically unstable patients in cardiogenic shock
- Concomitant aortic valve disease/surgery
- Previous mitral valve repair
- Impaired left ventricular systolic function as defined by a left ventricular ejection fraction of ≤ 50%.
- If the patient lives out of state or cannot attend follow up visits.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03290872
Start Date
September 1 2017
End Date
September 1 2019
Last Update
September 25 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.